Alyeska Investment Group, L.P. Synthetic Biologics, Inc. Call Options Transaction History

Alyeska Investment Group, L.P.

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2018 Nov 14, 2018	BUY	$20.4 - $80.5 $102 Million - $403 Million	5,000,000 New	5,000,000 $13 Million

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.